Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma von Mason, Robert, Dearden, Helen C., Nguyen, Bella, Soon, Jennifer A., Smith, Jessica Louise, Randhawa, Manreet, Mant, Andrew, Warburton, Lydai, Lo, Serigne, Meniawy, Tarek, Guminski, Alexander, Parente, Phillip, Ali, Sayed, Haydon, Andrew, Long, Georgina V., Carlino, Matteo S., Millward, Michael, Atkinson, Victoria G., Menzies, Alexander M.

Volltext